Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Paclitaxel and Cisplatin for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma
NCT02395705Phase 3Completed
- Sponsor
- Henan Cancer Hospital
- Start
- Jun 2015
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Henan Cancer Hospital. Started Jun 2015; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02395705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395705.